3-Methoxy-N-((2-methyl-2,3-dihydrobenzofuran-5-yl)methyl)propan-1-amine

Catalog No. :
ACRWDN872
CAS No. :
878046-63-0
Molecular Formula :
C14H21NO2
Molecular Weight :
235.33

IUPAC Name:3-methoxy-N-((2-methyl-2,3-dihydrobenzofuran-5-yl)methyl)propan-1-amine

3-Methoxy-N-((2-methyl-2,3-dihydrobenzofuran-5-yl)methyl)propan-1-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$272.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methoxy-N-((2-methyl-2,3-dihydrobenzofuran-5-yl)methyl)propan-1-amine
IUPAC Name3-methoxy-N-((2-methyl-2,3-dihydrobenzofuran-5-yl)methyl)propan-1-amine
MDL No.MFCD08056146
Molecular FormulaC14H21NO2
Molecular Weight235.33
SMILESCC1OC2=CC=C(CNCCCOC)C=C2C1
InChI KeyDXAVLEBTUDGOIZ-UHFFFAOYSA-N
SynonymTIMTEC-BB SBB011733;ASINEX-REAG BAS 16150140;(3-METHOXY-PROPYL)-(2-METHYL-2,3-DIHYDRO-BENZOFURAN-5-YLMETHYL)-AMINE;AKOS BC-1941;5-Benzofuranmethanamine, 2,3-dihydro-N-(3-methoxypropyl)-2-methyl-;3-Methoxy-N-((2-methyl-2,3-dihydrobenzofuran-5-yl)methyl)propan-1-amine
CAS No.878046-63-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRWDN872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBWAG179 route compound structure diagram
    ACBWAG17918600-41-4 In Stock
  4. Then
  5. ACRWDN872 route product structure diagram
    ACRWDN872878046-63-0
Inquiry

2. ACRWDN872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRWDN872 route product structure diagram
    ACRWDN872878046-63-0
Inquiry

Comments (0)